Leading brokers reiterate buy rating on this ASX healthcare share

Why ASX healthcare share Ansell Limited (ASX: ANN) has received a series of broker upgrades following its trading update

| More on:
asx shares to buy and hold represented by man happily hugging himself

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

The Ansell Limited (ASX: ANN) share price has received a series of big broker share price updates following its trading update. Ansell has been a standout performer among ASX200 healthcare shares given its market leading position within the personal protective equipment sector. 

Ansell's trading update 

Ansell provided a trading update ahead of its 2020 AGM that should take place this week. The update upgraded its guidance for FY21, with the company experiencing continued strength in its business despite the continued uncertainties arising from COVID-19.

The update highlighted better than anticipated production volumes and sales across all five of its strategic business units, supplier cost increases being successfully managed, capex investments including capacity increases progressing to plan and more favourable exchange rates. Based on these developments, the company is now expecting organic growth to be in double digits and earnings per share (EPS) to be in the range of 135 to 145 cents (up from previous guidance of 126 to 138 cents). 

From an earlier capital markets presentation on 15 October, Ansell highlighted that global demand for exam and single use products had tripled. This was driven by healthcare, frontline workers and new hygiene protocols in other industries. It cited an estimated 370 billion gloves were currently produced annually, However, an estimated 585 billion gloves were needed, resulting in capacity increases taking place. 

Big broker upgrades 

Ansell was previously an underperforming ASX200 healthcare share that delivered minimal shareholder return throughout 2015 to 2020. COVID-19 has been a huge turning point for the business' growth trajectory.

Ansell has since received a series of broker upgrades as of Monday.

Citi retained its buy rating and a price target of $41.00. It was pleased with the better guidance on earnings and that company costs are under control. 

Credit Suisse raised its Ansell share price target from $43.00 to $45.00 and retains an outperform rating. It reacted positively to the FY21 upgrade, and upgrades expected earnings by 7% for FY21. 

Morgan Stanley retained an overweight rating and price target of $43.50. It notes solid progress on Ansell's costs despite increasing manufacturing capacity. 

Finally, UBS raised its Ansell share price target from $39.00 to $41.75 and retains a neutral rating. It was pleased with the company's increased operational efficiencies, organic growth and growth potential. However, it is cautious at its current valuation. 

Motley Fool contributor Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ansell Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit face palms at the downturn happening with shares today.
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »

Workers at the port joyfully jump high in the air with shipping containers in the background.
Industrials Shares

$10,000 invested in Austal shares a year ago is now worth…

Austal is an Australian shipbuilding company founded in 1988 that builds ships for the US Navy.

Read more »

a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
Broker Notes

5 Australian shares to buy with $5,000

Brokers are urging investors to snap up these shares right now.

Read more »

A male ASX 200 broker wearing a blue shirt and black tie holds one hand to his chin with the other arm crossed across his body as he watches stock prices on a digital screen while deep in thought
Share Market News

5 things to watch on the ASX 200 on Monday

Let's see what is expected on the local market today.

Read more »

Broker Notes

Broker warns regulated electricity could threaten AGL shares 

What could the government review mean for utility stocks?

Read more »

An oil worker assesses productivity at an oil rig as ASX 200 energy shares continue to rise.
Share Market News

ASX 200 energy shares lead for the second week as world awaits US decision on Iran

ASX energy shares lifted 5.31% while the ASX 200 fell 0.49% amid the US President contemplating strikes.

Read more »

Two brokers analysing stocks.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A young well-dressed couple at a luxury resort celebrate successful life choices.
Broker Notes

These ASX 200 shares could rise 40% to 50%

Analysts at Macquarie see potential for these shares to deliver the goods for investors.

Read more »